Ratnakar Securities Pvt. Ltd.

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt

BSE1490.0024.65 (+1.68 %)

PREV CLOSE ( ) 1465.35

OPEN PRICE ( ) 1465.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 28730

TODAY'S LOW / HIGH ( )1453.60 1503.45

52 WK LOW / HIGH ( )489.2 1678.6

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-07 1999

Management Info

Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director

Registered Office

Address D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone 0240-6632222 / 6694444

Email investorrelations@wockhardt.com

Website www.wockhardt.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

22May Wockhardt informs about annual secret
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure R..

09Apr Wockhardtâ€™s arm incorporates Wholly
Wockhardtâ€™s subsidiary -- Wockhardt Bio AG has incorporated a new Whol..

01Apr Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..

03Feb Wockhardt informs about board meeting
Wockhardt has informed that a meeting of the Board of Directors of the C..

31Jan Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	400	-120
Gross Profit	400	-120
Operating Profit	1200	3550
Net Sales	3550	14020

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 31061.15 (1.30%)	M.Cap ( in Cr)66744.06
Neuland Laboratories (BSE) 11807.55 (1.13%)	M.Cap ( in Cr)15125.16
Pfizer (BSE) 5695.95 (1.36%)	M.Cap ( in Cr)25985.17
Sanofi India (BSE) 6216.95 (1.25%)	M.Cap ( in Cr)14283.82
Eris Lifesciences (BSE) 1604.70 (2.54%)	M.Cap ( in Cr)21888.34

Shareholding Pattern

	MUTUAL FUNDS/UTI	7.56%
	PROMOTERS	49.09%
	NON-INSTITUTION	33.49%
	FI/BANKS/INSURANCE	0.51%
	GOVERNMENT	0.02%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Samco Active Moment...	7.64
ITI Focused Equity ...	4.43
Tata India Pharma &...	3.31
HDFC Pharma and Hea...	2.99
Mirae Asset Healthc...	2.76
Bandhan Business Cy...	2.27

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

WOCKHARDT LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES